IP Library Granted Patent US 8,486,899
Granted Patent B2
US 8,486,899 · App. 13/127,688 · Granted Jul 16, 2013

Antioxidant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,486,899
App. No.
13/127,688
Granted
Jul 16, 2013
Kind
B2
Abstract

To provide an antioxidant which is highly safe, inhibits oxidation of a biological component, in particular, a lipid, and is used as a drug, food or drink, a food additive, an external preparation for skin, or the like. The antioxidant contains 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol as an active ingredient.

Claims (7)

1. A method of treating one or more disease or symptom of skin selected from the group consisting of skin roughness, skin aging, dermatitis, pigmentation, wrinkles, a decrease in skin elasticity and alopecia, comprising administering a compound represented by the following chemical formula (1) to a subject in need of treatment

2. The method according to claim 1 , comprising administering a composition containing the compound represented by the chemical formula (I) at a concentration of at least 0.0001% by mass.

3. The method according to claim 2 , wherein the composition is a drug.

4. The method according to claim 2 , wherein the composition is an external preparation for skin.

5. The method according to claim 2 , wherein the composition is food or drink.

6. The method according to claim 5 , wherein the food or drink contains an emulsifier.

7. The method according to claim 2 , wherein the composition is a food additive, and containing at least 0.001% by mass of the compound.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Dec 10, 2021
From: PNC BANK, NATIONAL ASSOCIATION
To: NEEDLETECH PRODUCTS, INC.; GALT MEDICAL CORPORATION; C.P. MEDICAL CORPORATION; JUNIPER HOLDINGS, INC.; THERAGENICS CORPORATION
Reel/Frame 058360/0580 →
RELEASE OF SECURITY INTEREST Recorded Nov 25, 2021
From: PNC BANK, NATIONAL ASSOCIATION
To: THERAGENICS CORPORATION; C.P. MEDICAL CORPORATION; GALT MEDICAL CORP.; NEEDLETECH PRODUCTS, INC.
Reel/Frame 058251/0163 →
RELEASE OF SECURITY INTEREST Recorded Oct 21, 2021
From: PNC BANK, NATIONAL ASSOCIATION
To: THERAGENICS CORPORATION; NEEDLETECH PRODUCTS, INC.; GALT MEDICAL CORP.; C.P. MEDICAL CORPORATION
Reel/Frame 057889/0019 →
SECURITY INTEREST Recorded Feb 4, 2016
From: THERAGENICS CORPORATION; NEEDLETECH PRODUCTS, INC.; GALT MEDICAL CORP.; C.P. MEDICAL CORPORATION
To: PNC BANK, NATIONAL ASSOCIATION
Reel/Frame 037664/0962 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 5, 2011
From: TANAKA, MIYUKI; NOMAGUCHI, KOUJI; EHARA, TATSUYA
To: MORINAGA MILK INDUSTRY CO., LTD.
Reel/Frame 026232/0059 →